Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | $ 970.00 |
Description | Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer. |
Synonyms | NSC644591 NSCD644591 SKI2053R, Heptaplatin Sunpla, HTP |
Molecular Weight | 471.36 |
Formula | C11H20N2O6Pt |
CAS No. | 146665-77-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Heptaplatin 146665-77-2 NSC644591 NSCD644591 SKI2053R Heptaplatin Sunpla HTP inhibitor inhibit